Wolverine Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Wolverine Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-36,216	Closed	-$2.73M	–	2832
2022 Q2	$2.73M	Buy	+36,216	New	+$1.61M	0.03%	466

Wolverine Asset Management's TPTX Position: Q3 2022 in Review

Wolverine Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 36,216 shares — an estimated $2.73M sold.

Wolverine Asset Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $2.73M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Wolverine Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Wolverine Asset Management sold 36,216 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.73M.
Wolverine Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Wolverine Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $2.73M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Wolverine Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.